Collection of samples and data across the following diseases: Malignant tumour of breast Window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO)
Description
More detailed information about this field from each metasource.
Collection of samples and data across the following diseases: Malignant tumour of breast Window study of the PARP inhibitor rucaparib in patients with primary triple negative or BRCA1/2 related breast cancer (RIO)
metasource: HDR UK version: extracted_at: 2022-09-05T08:28:24.125862